- Home
- KMDA vs CHW Comparison
KMDA vs CHW Comparison
Compare KMDA & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- CHW
- Stock Information
- Founded
- KMDA 1990
- CHW 2007
- Country
- KMDA Israel
- CHW United States
- Employees
- KMDA N/A
- CHW N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- CHW Investment Managers
- Sector
- KMDA Health Care
- CHW Finance
- Exchange
- KMDA Nasdaq
- CHW Nasdaq
- Market Cap
- KMDA 380.7M
- CHW 383.8M
- IPO Year
- KMDA N/A
- CHW N/A
- Fundamental
- Price
- KMDA $6.89
- CHW $6.74
- Analyst Decision
- KMDA Strong Buy
- CHW
- Analyst Count
- KMDA 3
- CHW 0
- Target Price
- KMDA $14.67
- CHW N/A
- AVG Volume (30 Days)
- KMDA 53.8K
- CHW 195.2K
- Earning Date
- KMDA 05-14-2025
- CHW 01-01-0001
- Dividend Yield
- KMDA 2.89%
- CHW 9.27%
- EPS Growth
- KMDA 66.67
- CHW N/A
- EPS
- KMDA 0.25
- CHW N/A
- Revenue
- KMDA $160,953,000.00
- CHW N/A
- Revenue This Year
- KMDA $14.01
- CHW N/A
- Revenue Next Year
- KMDA $9.24
- CHW N/A
- P/E Ratio
- KMDA $27.37
- CHW N/A
- Revenue Growth
- KMDA 12.93
- CHW N/A
- 52 Week Low
- KMDA $4.74
- CHW $5.07
- 52 Week High
- KMDA $9.15
- CHW $6.54
- Technical
- Relative Strength Index (RSI)
- KMDA 58.32
- CHW 66.56
- Support Level
- KMDA $6.69
- CHW $6.51
- Resistance Level
- KMDA $7.10
- CHW $6.79
- Average True Range (ATR)
- KMDA 0.16
- CHW 0.10
- MACD
- KMDA 0.05
- CHW 0.05
- Stochastic Oscillator
- KMDA 72.00
- CHW 91.67
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.